Curis

Showing 2 posts of 2 posts found.

Roche image

Roche’s Erivedge gains conditional EU approval

July 15, 2013
Sales and Marketing Curis, EU, Erivedge, Roche, Swiss, Zelboraf

Roche’s cancer pill Erivedge has received a conditional European approval for treatment of the most common type of skin cancer. …

Roche's Swiss headquarters

Roche’s skin cancer drug passes mid-stage trial

March 22, 2011
Research and Development Curis, Roche, advanced basal cell carcinoma, skin cancer, vismodegib

Roche’s skin cancer candidate vismodegib has met its primary endpoint in a phase II trial. The drug is being tested …

The Gateway to Local Adoption Series

Latest content